TNFA - TNF Pharmaceuticals, Inc.
0.19
-0.007 -3.474%
Share volume: 1,234,724
Last Updated: 05-09-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$0.20
-0.01
-0.03%
Summary score
14%
Profitability
0%
Dept financing
13%
Liquidity
7%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-38.22%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
31.63%
Debt ratio change over timeo
0%
Current Ratio
1.17%
Quick Ratio
0%
Cash Position Ratio
0.11%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-38.22%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
31.63%
Debt ratio change over timeo
0%
Current Ratio
1.17%
Quick Ratio
0%
Cash Position Ratio
0.11%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-67.74%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
32.43%
Debt ratio change over time
0%
Current Ratio
0.62%
Quick Ratio
0%
Cash Position Ratio
0.06%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | TNFA | IDXX | LNTH | QDEL |
---|---|---|---|---|
Return on equity | 0% | 29.07% | 1.91% | 16.9% |
Return on assets | -38.22% | 9.05% | 1.74% | 15.98% |
Return on sales | 0% | 28.32% | 5.19% | 54.32% |
Return on invested capital | 0% | 29.43% | 4.93% | 49.95% |
Profitability | 0% | 67% | 9% | 90% |
Total debt ratio | 31.63% | 70.69% | 47.8% | 26.73% |
Debt ratio change over time | 0% | 1.36% | -12.04% | 0.99% |
Dept financing | 11% | 50% | 17% | 28% |
Current Ratio | 1.17% | 1.48% | 5.22% | 0% |
Quick Ratio | 0% | 1.06% | 4.9% | 0% |
Cash Position Ratio | 0.11% | 0.35% | 3.25% | 0% |
Liquididy | 10% | 22% | 68% | 75% |
Short-term ratios | TNFA | IDXX | LNTH | QDEL |
---|---|---|---|---|
Return on equity | 0% | 18.43% | 16.2% | 0% |
Return on assets | -38.22% | 8.92% | 7.82% | 0% |
Return on sales | 0% | 29.92% | 35.34% | 0% |
Return on invested capital | 0% | 28.37% | 27.48% | 0% |
Profitability | 0% | 96% | 93% | 0% |
Total debt ratio | 31.63% | 56.88% | 52.93% | 0% |
Debt ratio change over time | 0% | 0.89% | -15.22% | 0% |
Dept financing | 14% | 50% | 23% | 0% |
Current Ratio | 1.17% | 1.48% | 5.22% | 0% |
Quick Ratio | 0% | 1.06% | 4.9% | 0% |
Cash Position Ratio | 0.11% | 0.35% | 3.25% | 0% |
Liquididy | 6% | 15% | 75% | 0% |